ROCK1 and esophageal squamous cell carcinoma: Collectively, these data reveal that ARL5B drives lipid synthesis and tumor progression via ROCK1‐mediated activation of SREBP1, providing mechanistic insights into how metabolic alterations fuel ESCC aggressiveness.